The report " Scleroderma Treatment Market by Drug Class (Anti- Inflammatory drugs, immunosuppressants, PDE5 inhibitors, calcium channel blockers, and others), by Indication (Localized, Systemic), by Distribution Channels (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies)- Global Forecasts to 2030"
The report " Erythropoietin Stimulating Agents Market by Product Type (Epoetin-Alfa, Epoetin-Beta, Epoetin-Delta, Epoetin-Omega, Darbepoetin-Alfa, Others), by Application (Oncology, Renal Disorders, Anemia, Surgeries, Others), by Distribution Channel (Hospital Pharmacies, retail Pharmacies, Online Pharmacies)- Global Forecasts to 2030”.
The report " Technology Spending on Core Administration in Healthcare Market by Solution (In-House and Outsource), by Deployment (Cloud-Based and On-Premises), by End User (Payers and Providers)- Global Forecasts to 2030"
The global technology spending on core administration in healthcare market is projected to reach USD 35.9 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period 2024-2030.
The report " Mesothelioma Treatment Market by Drug Class (Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, and Others), by Application (Pleural Mesothelioma and Peritoneal Mesothelioma), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Global Forecasts to 2030"
The report " Haitian Vetiver Oil Market by Product Type (Organic and Conventional), by Application (Pharmaceuticals, Food and Beverages, Perfume and Scent Products, and Others- Global Forecasts to 2030"
The global haitian vetiver oil market is projected to reach USD 28.4 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 1.8% during the forecast period 2024-2030. The growth of the market is majorly driven by the growing demand for haitian vetiver oil from the fragrance industry.
The report " Organ and Tissue Transplantation Market by Product (Immunosuppressants, Preservation Solutions, and Tissue Products), by Application (Organ Transplantation (Heart, Lungs, Liver, Kidney, Intestine/Small Bowel, Pancreas), by Tissue Transplantation (Skin Transplantation, Cellular Transplantation, Cornea, Vascular Transplantation, Bone Graft Transplantation)), by End User (Hospitals, Transplantation Centers, Others)- Global Forecasts to 2030"
The report " Blockchain Market by Component (Platform/Solution, Blockchain as a Service), By Blockchain Type (Public, Private, Hybrid), by Provider (Application & Solution, Infrastructure & Protocols, Middleware), by End User Industry (Agriculture and Food, Retail and Ecommerce, Energy and Utilities, Healthcare and Life Science, Insurance, IT and Telecom, Manufacturing, Media, Advertising and Entertainment, Banking and Financial Services, Transportation and Logistics Others)- Global Forecasts to 2030"
The report " Drone Services Market by Service Type (Platform Service, Maintenance Repair Overhaul (MRO), Simulation & Training), by Application (Inspection & Monitoring, Mapping & Surveying, Spraying & Seeding, Filming & Photography, Transport & Delivery, Security, Search & Rescue), by End User (Construction & Infrastructure, Agriculture, Oil & Gas, Mining, Defence & Law Enforcement, Media & Entertainment, Aviation, Transport, Logistics & Warehousing Others) - Global Forecasts to 2030"
The report " Dipeptidyl Peptidase Iv Dpp Iv Inhibitors Market by Drug Type (Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Others), by Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Global Forecasts to 2030"
The global dipeptidyl peptidase iv (dpp) iv inhibitors market is projected to reach USD 16.43 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 5% during the forecast period 2024-2030.
The report " Childhood Vaccines Market by Vaccine Type (Inactivated Vaccines, Attenuated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, Others), by Route of Administration (Oral, Intramuscular, Intradermal, Subcutaneous, Intranasal), by Application (Diphtheria, Pertussis, Tetanus, Polio, Measles, Hepatitis-B, Others), by Composition (Mono vaccines, Combination vaccines), by End-user (Hospitals, Clinics, Vaccination Centres)- Global Forecasts to 2030"
